Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunological Methods|November 24, 2018
Improving TCR affinity on 293T cellsRieko Ohta, Ayako Demachi-Okamura, Yoshiki Akatsuka, et al.
Plos One|October 17, 2012
Autophagy creates a CTL epitope that mimics tumor-associated antigensAyako Demachi-Okamura, Hiroki Torikai, Yoshiki Akatsuka, et al.
Cancer Science|June 15, 2011
Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinomaShiro Suzuki, Toshiaki Yoshikawa, Tomoya Hirosawa, et al.
International Journal of Hematology|April 17, 2008
Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantationHiroki Torikai, Yoshiki Akatsuka, Yasushi Yatabe, et al.
Cancer Science|August 30, 2008
Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cellsAyako Demachi-Okamura, Yoshinori Ito, Yoshiki Akatsuka, et al.
European Journal of Immunology|February 16, 2006
Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignanciesAyako Demachi-Okamura, Yoshinori Ito, Yoshiki Akatsuka, et al.
International Immunology|October 21, 2003
Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the alpha1/alpha2 domain of TL free from antigenic peptidesKunio Tsujimura, Yuichi Obata, Eisei Kondo, et al.
Pageof 9